8-K ·Filed May 8, 2026
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral
Monitor DGX's leverage ratios and upcoming debt maturities. The 5% coupon is unremarkable for an A-rated issuer. No near-term equity catalyst.
Final — all horizons settled through T+60d
DGX ▲ +24.25% at T+60d
NEUTRAL call ✓ call won +24.25% · α vs SPY +19.86% · entry $189.81 → $235.84
T+1d
+0.19%
call +0.19% · α +0.33%
$190.18
settled 5mo ago
T+5d
+0.02%
call +0.02% · α +0.10%
$189.84
settled 5mo ago
T+20d
+7.76%
call +7.76% · α +8.06%
$204.53
settled 4mo ago
T+60d
+24.25%
call +24.25% · α +19.86%
$235.84
settled 8w ago
Price Chart
Loading chart...
Executive Summary
Quest Diagnostics issued $500M of 5.000% senior notes due 2036, a routine debt refinancing/capital raise. The notes are senior unsecured obligations and rank equally with existing debt. The filing has no impact on equity fundamentals or operations.
Key Facts
- Issued $500,000,000 aggregate principal of 5.000% senior notes due 2036.
- Interest payable semi-annually on June 30 and December 30, starting December 30, 2026.
- Notes mature on June 30, 2036.
- Notes are senior unsecured obligations, ranking equally with existing and future senior unsecured debt.
- Upon a change of control triggering event, holders may require repurchase at 101% of principal plus accrued interest.
Financial Impact
No impact on revenue, earnings, or cash flow. Increases long-term debt by $500M with 5% fixed coupon.
debt
Risk Factors
- Higher interest expense (approx. $25M annually) could modestly pressure net income.
- Increased leverage may limit financial flexibility for future acquisitions.
Market Snapshot
Exchange
NYSE
Sector
Services-Medical Laboratories
Analyst Consensus
54% bullish (24 analysts)
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-057938 |
| Document: tm2613096d2_ex5-1.htm | 0001104659-26-057938 |
| Document: tm2613096d2_8k.htm | 0001104659-26-057938 |
| Document: 0001104659-26-057938-index-headers.html | 0001104659-26-057938 |
| Document: 0001104659-26-057938-index.html | 0001104659-26-057938 |
| Document: 0001104659-26-057938.txt | 0001104659-26-057938 |
9 reports for DGX
100% Hit rate best @ T+5▲ +7.06%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Press Release | $231.14 $247.45 | ▲ +7.06% | ▲ +7.56% | $233.27 (+0.92%) |
Sep 3, 2026 29d ago | Insider Cluster | $239.40 $235.02 | ▼ −1.83% | ▼ −0.68% | $233.27 (−2.56%) |
Jul 23, 2026 10w ago | 8-K | $227.90 $234.30 | ▲ +2.81% | ▲ +2.33% | $233.27 (+2.36%) |
May 8, 2026 20w ago | 8-K | $189.81 $189.84 | ▲ +0.02% | ▲ +0.10% | $233.27 (+22.90%) |
Apr 21, 2026 23w ago | 8-K | $205.04 $195.05 | ▼ −4.87% | ▼ −5.96% | $233.27 (+13.77%) |
Apr 16, 2026 24w ago | Court Ruling | $191.46 $199.53 | ▲ +4.21% | ▲ +3.25% | $233.27 (+21.84%) |
Mar 5, 2026 30w ago | Insider Cluster | $203.09 $200.01 | ▲ +1.52% | ▼ −0.72% | $233.27 (−14.86%) |
Mar 3, 2026 30w ago | Insider Cluster | $207.46 $200.03 | ▼ −3.58% | ▼ −3.10% | $233.27 (+12.44%) |
Mar 3, 2026 30w ago | Insider Cluster | $207.46 $200.03 | ▼ −3.58% | ▼ −3.10% | $233.27 (+12.44%) |
Showing 9 of 9
US Market Status
Market Closed — Opens Mon (65h 22m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access